ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MRK Merck and Co Inc

128.30
0.93 (0.73%)
Pre Market
Last Updated: 21:49:24
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.93 0.73% 128.30 21:49:24
Open Price Low Price High Price Close Price Previous Close
127.37
more quote information »

Recent News

Date Time Source Heading
21/2/202408:14EDGAR2Form 8-K - Current report
20/2/202422:45BWFDA Grants Priority Review to Merck's Application for..
16/2/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202408:40EDGAR2Form 144 - Report of proposed sale of securities
15/2/202408:30EDGAR2Form 144 - Report of proposed sale of securities
15/2/202408:24EDGAR2Form 144 - Report of proposed sale of securities
14/2/202408:50EDGAR2Form 144 - Report of proposed sale of securities
14/2/202408:48EDGAR2Form 144 - Report of proposed sale of securities
13/2/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202423:05PRNCAHealth Canada Approves KEYTRUDA® in combination with..
10/2/202408:06EDGAR2Form 144 - Report of proposed sale of securities
09/2/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:00PRNCAMERCK CANADA ANNONCE UNE COLLABORATION AVEC L'INSTITUT..
08/2/202408:09EDGAR2Form 144 - Report of proposed sale of securities
06/2/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:33BWMerck Animal Health to Acquire Elanco’s Aqua Business
03/2/202408:35EDGAR2Form 144 - Report of proposed sale of securities
03/2/202408:09EDGAR2Form 144 - Report of proposed sale of securities
03/2/202408:08EDGAR2Form 144 - Report of proposed sale of securities
03/2/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:39EDGAR2Form 8-K - Current report
01/2/202422:30BWMerck Announces Fourth-Quarter and Full-Year 2023 Financial..
28/1/202402:00BWMerck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Death..
27/1/202403:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/1/202402:00BWMerck’s KEYTRUDA® (pembrolizumab) Significantly Improved..
26/1/202400:07DJNLava Therapeutics Shares Rise as Drug Set for Test With..
25/1/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202407:29EDGAR2Form SC 13G - Statement of acquisition of beneficial..
24/1/202406:44BWMerck Announces Second-Quarter 2024 Dividend
23/1/202422:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
19/1/202422:45BWMerck to Hold Fourth-Quarter and Full-Year 2023 Sales and..
16/1/202400:15PRNUSMerck Animal Health's Fourth Veterinary Wellbeing Study..
13/1/202410:13DJNMerck's Keytruda Combined with Chemoradiotherapy Gets FDA..
13/1/202409:30BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus..
10/1/202402:21DJNMerck on Track for Record High Close -- Data Talk
09/1/202422:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
09/1/202406:54DJNTrending: Johnson & Johnson and Merck & Co. Announce..
09/1/202400:45IHNWExciting New Cures Possible from GLP-1 Diabetes, Weight-Loss..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com